NCT00238901View on ClinicalTrials.gov

Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation

PHASE3CompletedINTERVENTIONAL

Enrollment

194

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

July 31, 2005

Conditions

Liver Transplant

Interventions

DRUG

Basiliximab

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY